Hoth Therapeutics Inc [NASDAQ: HOTH] stock went on an upward path that rose over 10.34% on Tuesday, amounting to a one-week price increase of more than 2.42%.
Over the last 12 months, HOTH stock rose by 71.10%. The one-year Hoth Therapeutics Inc stock forecast points to a potential upside of 74.4. The average equity rating for HOTH stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $16.97 million, with 13.23 million shares outstanding and 12.70 million shares in the current float. Compared to the average trading volume of 1.14M shares, HOTH stock reached a trading volume of 20061141 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Hoth Therapeutics Inc [HOTH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HOTH shares is $5.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HOTH stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Benchmark Company have made an estimate for Hoth Therapeutics Inc shares, keeping their opinion on the stock as Speculative Buy, with their previous recommendation back on October 15, 2019.
The Price to Book ratio for the last quarter was 1.74, with the Price to Cash per share for the same quarter was set at 0.68.
HOTH Stock Performance Analysis:
Hoth Therapeutics Inc [HOTH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.42. With this latest performance, HOTH shares dropped by -1.92% in over the last four-week period, additionally plugging by 47.13% over the last 6 months – not to mention a rise of 71.10% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HOTH stock in for the last two-week period is set at 51.75, with the RSI for the last a single of trading hit 0.0900, and the three-weeks RSI is set at 0.0933 for Hoth Therapeutics Inc [HOTH]. The present Moving Average for the last 50 days of trading for this stock 1.2819, while it was recorded at 1.2180 for the last single week of trading, and 1.0842 for the last 200 days.
Hoth Therapeutics Inc (HOTH) Capital Structure & Debt Analysis
According to recent financial data for Hoth Therapeutics Inc. ( HOTH), the Return on Equity (ROE) stands at -106.80%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -101.19%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Hoth Therapeutics Inc’s Return on Invested Capital (ROIC) is -104.59%, showcasing its effectiveness in deploying capital for earnings.
Hoth Therapeutics Inc (HOTH) Efficiency & Liquidity Metrics
Based on Hoth Therapeutics Inc’s (HOTH) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Hoth Therapeutics Inc (HOTH) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Hoth Therapeutics Inc. (HOTH) effectively leverages its workforce, generating an average of -$1698333.33 per employee. The company’s liquidity position is robust, with a Current Ratio of 27.57% and a Quick Ratio of 27.57%, indicating strong ability to cover short-term liabilities.
HOTH Stock EPS
With the latest financial reports released by the company, Hoth Therapeutics Inc posted -0.31/share EPS, while the average EPS was predicted by analysts to be reported at -0.3/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.01. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HOTH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Hoth Therapeutics Inc go to 18.08%.
Hoth Therapeutics Inc [HOTH] Institutonal Ownership Details
There are presently around $1.98%, or 2.06%% of HOTH stock, in the hands of institutional investors. The top three institutional holders of HOTH stocks are: ARMISTICE CAPITAL, LLC with ownership of 0.21 million shares, which is approximately 3.0976%. UBS GROUP AG, holding 43355.0 shares of the stock with an approximate value of $$39409.0 in HOTH stocks shares; and UBS GROUP AG, currently with $$35284.0 in HOTH stock with ownership which is approximately 0.5643%.
